Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 6.18%5.74B | ---- | 13.09%5.41B | ---- | -16.64%4.78B | ---- | -4.34%5.73B | ---- | 18.74%5.99B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -3.81%-430.86M | ---- | -2.51%-415.05M | ---- | 30.89%-404.87M | ---- | -7.90%-585.85M | ---- | 2.83%-542.94M |
| Interest expense - adjustment | ---- | -37.46%176.23M | ---- | 26.97%281.79M | ---- | 35.05%221.93M | ---- | -21.14%164.33M | ---- | -33.33%208.38M |
| Attributable subsidiary (profit) loss | ---- | 84.12%-67K | ---- | -105.08%-422K | ---- | 272.06%8.31M | ---- | 5.43%2.23M | ---- | -36.85%2.12M |
| Impairment and provisions: | ---- | -43.50%30.51M | ---- | -2.08%54M | ---- | 521.96%55.15M | ---- | -82.23%8.87M | ---- | 20.10%49.9M |
| -Impairmen of inventory (reversal) | ---- | -42.73%20.28M | ---- | -4.27%35.41M | ---- | -13.29%36.99M | ---- | -1.39%42.66M | ---- | -25.67%43.26M |
| -Impairment of trade receivables (reversal) | ---- | -44.97%10.23M | ---- | 2.38%18.59M | ---- | 153.73%18.16M | ---- | -609.10%-33.79M | ---- | 139.86%6.64M |
| Asset sale loss (gain): | ---- | 125.21%14.23M | ---- | 167.60%6.32M | ---- | -381.43%-9.35M | ---- | 101.44%3.32M | ---- | -2,923.07%-230.14M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---2.33M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 73.28%14.23M | ---- | 187.86%8.21M | ---- | -381.43%-9.35M | ---- | 101.44%3.32M | ---- | -2,923.07%-230.14M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | --439K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -5.33%921.6M | ---- | 4.38%973.5M | ---- | -1.07%932.65M | ---- | 0.11%942.71M | ---- | 3.95%941.68M |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -0.38%820.99M |
| -Amortization of intangible assets | ---- | 41.97%1.6M | ---- | -62.71%1.13M | ---- | 52.09%3.02M | ---- | -26.22%1.99M | ---- | 0.04%2.69M |
| Operating profit before the change of operating capital | ---- | 2.31%6.45B | ---- | 12.93%6.31B | ---- | -10.94%5.58B | ---- | -2.39%6.27B | ---- | 11.50%6.42B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -126.22%-181.36M | ---- | 1,368.77%691.64M | ---- | 106.36%47.09M | ---- | -525.09%-740.03M | ---- | 141.78%174.09M |
| Accounts receivable (increase)decrease | ---- | 836.13%29.02M | ---- | -97.66%3.1M | ---- | 361.17%132.44M | ---- | 36.54%-50.71M | ---- | -139.01%-79.92M |
| Accounts payable increase (decrease) | ---- | -240.54%-164.27M | ---- | 114.69%116.89M | ---- | -372.17%-795.48M | ---- | -22.15%292.28M | ---- | -4.76%375.44M |
| prepayments (increase)decrease | ---- | -28.70%-114.73M | ---- | -131.72%-89.15M | ---- | 222.16%281.04M | ---- | -260.96%-230.06M | ---- | -223.33%-63.73M |
| Special items for working capital changes | ---- | 27.47%-199.61M | ---- | -181.82%-275.2M | ---- | 211.67%336.33M | ---- | -980.78%-301.19M | ---- | -105.97%-27.87M |
| Cash from business operations | -13.45%1.83B | -13.81%5.82B | -19.57%2.11B | 20.91%6.75B | 8.48%2.63B | 6.58%5.59B | -9.41%2.42B | -22.96%5.24B | -6.39%2.67B | 6.42%6.8B |
| Other taxs | 20.14%-518.18M | -10.50%-1.58B | -12.43%-648.85M | -6.83%-1.43B | -2.00%-577.13M | 23.01%-1.34B | 28.01%-565.8M | -6.78%-1.74B | -29.15%-785.89M | 6.42%-1.63B |
| Interest received - operating | 7.25%53.91M | -15.10%78.87M | 26.58%50.27M | -51.02%92.9M | -67.57%39.72M | -65.60%189.68M | -22.17%122.47M | 27.76%551.38M | -23.78%157.37M | -11.08%431.57M |
| Interest paid - operating | 26.54%-60.24M | 39.89%-160.56M | 43.48%-82.01M | -21.32%-267.11M | -102.07%-145.09M | -50.97%-220.18M | 4.73%-71.8M | 24.32%-145.84M | 17.49%-75.37M | 34.63%-192.72M |
| Net cash from operations | -8.95%1.31B | -19.21%4.16B | -26.33%1.43B | 22.11%5.15B | 2.00%1.95B | 7.88%4.22B | -3.20%1.91B | -27.79%3.91B | -16.63%1.97B | 11.77%5.42B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 20.96%123.6M | 212.83%330.07M | 34.74%102.18M | 8.59%105.51M | -2.98%75.84M | 4.55%97.16M | 2.02%78.16M | 1,058.92%92.93M | --76.61M | --8.02M |
| Decrease in deposits (increase) | 193.71%592.34M | 116.89%395.97M | 71.03%-632.12M | 12.01%-2.34B | -116.08%-2.18B | 13.96%-2.66B | -16.18%-1.01B | -8.67%-3.1B | ---869.05M | ---2.85B |
| Sale of fixed assets | 102.53%7.7M | 1,075.77%18.68M | 148.53%3.8M | -98.40%1.59M | -98.46%1.53M | 382.93%99.36M | 4,099.75%99.49M | -93.07%20.57M | -62.33%2.37M | 6,836.32%296.81M |
| Purchase of fixed assets | -222.45%-610.62M | -44.88%-633.46M | 28.10%-189.37M | 18.58%-437.23M | 1.00%-263.39M | -26.94%-537M | -25.07%-266.06M | -33.71%-423.03M | -33.20%-212.73M | -8.63%-316.39M |
| Purchase of intangible assets | -68.70%-11.66M | -130.65%-7.12M | -18.05%-6.91M | -62.25%-3.09M | -3,172.07%-5.86M | -87.94%-1.9M | 49.44%-179K | -9.88%-1.01M | 7.57%-354K | 81.15%-921K |
| Sale of subsidiaries | ---- | ---- | ---- | --110.52M | --103.29M | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | 131.57%1.58M | --875K | --681K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | -99.28%-153.71M | ---2.97M | 47.35%-77.13M | ---- | -478.60%-146.5M | ---126.32M | 51.04%-25.32M | ---- | ---51.71M |
| Net cash from investment operations | 113.99%101.35M | 98.19%-47.99M | 68.09%-724.52M | 16.16%-2.64B | -85.39%-2.27B | 8.14%-3.15B | -22.07%-1.22B | -17.80%-3.43B | -383.70%-1B | -898.46%-2.91B |
| Net cash before financing | 98.35%1.41B | 64.05%4.11B | 318.94%709.24M | 135.41%2.51B | -147.39%-323.94M | 123.03%1.07B | -29.38%683.52M | -80.91%477.6M | -55.12%967.93M | -45.07%2.5B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -32.80%1.77B | -67.34%4.51B | -73.58%2.64B | 298.49%13.82B | 405.03%10B | 2,941.01%3.47B | 3,859.97%1.98B | -97.88%114.01M | -98.73%50M | 18.07%5.38B |
| Refund | 24.27%-1.26B | 59.19%-5.71B | 78.88%-1.67B | -150.16%-14B | -126.92%-7.89B | -103.03%-5.6B | -127.26%-3.48B | 27.80%-2.76B | 32.55%-1.53B | 32.48%-3.82B |
| Dividends paid - financing | 38.15%-1.71B | -54.48%-2.77B | -54.48%-2.77B | 64.73%-1.79B | 56.78%-1.79B | -188.40%-5.08B | -266.38%-4.14B | 49.85%-1.76B | 62.17%-1.13B | -13.25%-3.51B |
| Absorb investment income | ---- | 200.09%9.81M | --2.01M | 137.85%3.27M | ---- | -89.08%1.37M | ---- | --12.58M | --12.58M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | 87.48%-36.63M | ---- | -260.77%-292.6M | ---11.83M | 90.10%-81.11M | ---- | 48.82%-819.49M | -3.36%-692.02M | -766.47%-1.6B |
| Other items of the financing business | ---- | ---26.18M | ---26.18M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 32.94%-1.27B | -70.81%-4.16B | -896.29%-1.89B | 67.21%-2.44B | 104.16%237.59M | -39.05%-7.43B | -69.80%-5.72B | -47.01%-5.34B | -65.73%-3.37B | 19.07%-3.63B |
| Effect of rate | 111.55%3.57M | -80.75%-125.54M | -172.38%-30.9M | -119.53%-69.45M | -104.05%-11.35M | 321.71%355.65M | 5,863.11%279.8M | -270.59%-160.41M | 88.69%-4.86M | -230.00%-43.29M |
| Net Cash | 111.68%138.14M | -166.20%-47.34M | -1,269.64%-1.18B | 101.12%71.5M | 98.28%-86.35M | -30.81%-6.36B | -109.82%-5.03B | -329.54%-4.86B | -2,016.89%-2.4B | -1,891.96%-1.13B |
| Begining period cash | -3.42%4.88B | 0.04%5.05B | 0.04%5.05B | -54.34%5.05B | -54.34%5.05B | -31.25%11.06B | -31.25%11.06B | -6.81%16.08B | -6.81%16.08B | 0.56%17.26B |
| Cash at the end | 30.82%5.02B | -3.42%4.88B | -22.50%3.84B | 0.04%5.05B | -21.45%4.95B | -54.34%5.05B | -53.92%6.3B | -31.25%11.06B | -21.12%13.68B | -6.81%16.08B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | 45.72%11.45B | -0.89%8.35B | 20.06%7.85B | 6.50%8.42B | -24.47%6.54B | -29.81%7.91B | -37.21%8.66B | -29.94%11.27B | -20.44%13.8B | --16.08B |
| Bank deposits | ---- | ---- | ---- | ---- | ---- | 44.81%8.61B | ---- | 108.67%5.95B | ---3.72B | --2.85B |
| Cash and cash equivalent balance | 45.72%11.45B | -0.89%8.35B | 20.06%7.85B | -49.02%8.42B | -24.47%6.54B | -4.03%16.52B | -14.04%8.66B | -9.08%17.21B | -41.89%10.08B | --18.93B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.